Cerebral and cerebellar pseudoatrophy associated with valproic acid. Report of three pediatric cases. [PDF]
Ordoño-Saiz MV +10 more
europepmc +1 more source
[Epilepsy in cancer patients: primary prevention and the importance of high-risk patient screening]. [PDF]
López-Anguita S +4 more
europepmc +1 more source
[Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy]. [PDF]
Rubio-Nazábal E +3 more
europepmc +1 more source
Clinical characteristics of patients with epilepsy attending primary health care. [PDF]
Arteaga-Rodríguez C +3 more
europepmc +1 more source
[Peripheral stimulation of the trigeminal nerve by nasopharyngeal swabbing as a possible trigger of migraine attacks]. [PDF]
Madera J +4 more
europepmc +1 more source
Outras complicações cardíacas associadas ao uso da lamotrigina
A lamotrigina tem sido associada, em casos raros, a: -Síndrome de Brugada. -Morte cardíaca súbita (SCD). -Morte súbita inesperada na epilepsia (SUDEP).
Mercedes Guaia Memita Guaia
core +1 more source
Glucose Transporter Deficiency Syndrome Type 1 (Glut1-DS): New Insights From a Brazilian Cohort of Patients. [PDF]
Sobrinho LMF +11 more
europepmc +1 more source
Efecto de la lamotrigina en la prolongación del QTc y el ensanchamiento del QRS
No hay evidencia que sugiera que la lamotrigina cause prolongación del QTc a dosis terapéuticas. La lamotrigina parece provocar ensanchamiento del QRS. El riesgo global es menos significativo que el asociado a los antidepresivos tricíclicos.
Mercedes Guaia Memita Guaia
core +1 more source
Effetto della lamotrigina sul prolungamento del QTc e sull’ampliamento del QRS
Nessuna evidenza suggerisce che la lamotrigina causi prolungamento del QTc a dosi terapeutiche. La lamotrigina sembra causare allargamento del QRS. Il rischio complessivo è meno significativo rispetto a quello degli antidepressivi triciclici.
Mercedes Guaia Memita Guaia
core +1 more source
Pharmacological Interventions for Excoriation Behaviors in Alzheimer's Disease: An Empty Systematic Review of Clinical Trials. [PDF]
Campos VLM, Serafim AP.
europepmc +1 more source

